GoodRx AI Market Strategy Report - Online Pharmacies

Answer Capsule

GoodRx holds the second-highest brand presence in AI-generated pharmacy responses but ranks third in recommendation power, sitting behind Amazon Pharmacy and Cost Plus Drugs. The benchmark shows GoodRx appearing in 40.3% of all observations with a 13.3% valid recommendation coverage rate. Its clearest win is in pricing and cost evaluation prompts, where its coupon comparison model earns strong recommendation placement and its highest single-cluster authority value. The clearest weakness is a monthly AI authority value roughly one-third of the top two competitors, a gap concentrated in the comparison cluster where buyer intent is highest. The most direct opportunity is converting existing pricing-cluster strength into recommendation placement at the evaluation stage.

Who This Report Is For

This report is for GoodRx marketing, product, and strategy leaders evaluating AI recommendation visibility and competitive positioning in the online pharmacy category.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: GoodRx
• Category / market studied: Online Pharmacies
• Reporting month: June 2026
• AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity
• Public high-intent clusters: 3 (Discovery, Comparison, Pricing)
• AI observations analyzed: 1,431
• Competitors tracked: 9

Executive Summary

GoodRx occupies a structurally middle position in the online pharmacy AI recommendation landscape. With 576 total appearances across 1,431 observations, it is the second most frequently mentioned brand in the dataset. The benchmark reveals, however, a clear and measurable gap between visibility and recommendation conversion that separates GoodRx from the two category leaders.

GoodRx achieves 190 valid recommendations across all platforms, representing a 13.3% valid recommendation coverage rate. Its top-three rate of 10.8% and rank-one rate of 8.3% place it third in the category. When GoodRx is recommended, it tends to appear early in the shortlist, with an average recommended rank of 1.65, suggesting that AI systems that do select GoodRx place it prominently rather than as a trailing mention.

The strongest cluster for GoodRx is pricing and cost evaluation, where it captures $1.31 million in monthly AI authority value. This is its highest single-cluster performance and the prompt territory most aligned with its coupon comparison service model. The weakest cluster is comparison and alternatives, where GoodRx captures only $760,000 and trails Amazon Pharmacy by a factor of three.

The strongest platform signal is Copilot, where GoodRx achieves a 29.3% valid recommendation coverage rate and a net sentiment score of 0.62. The clearest platform gap is Google AI Mode, where GoodRx appears in 42.6% of observations but converts only 5.2% into valid recommendations, a wide visibility-to-recommendation gap concentrated on the platform with the broadest consumer reach in the dataset.

GoodRx captures an estimated $3.07 million in monthly AI authority value, compared to Amazon Pharmacy at $8.4 million and Cost Plus Drugs at $7.33 million. Its captured share of AI opportunity is 3.1%, placing it third but well behind the two leaders. The evidence suggests the gap is not a presence problem but a recommendation conversion problem, concentrated in the comparison cluster and on Google AI Mode.

What GoodRx Is Winning

Pricing cluster leadership. GoodRx performs strongest in pricing and cost evaluation prompts, where it captures $1.31 million in monthly AI authority value and achieves a rank-one rate of 12.6%. This is its highest rank-one performance across all clusters. AI systems appear to understand the coupon comparison model clearly in cost-specific prompts.

Strong Copilot recommendation signal. On Copilot, GoodRx achieves a 29.3% valid recommendation coverage rate and a 0.62 net sentiment score, its strongest platform performance on both measures. This represents a meaningful and defensible recommendation pocket.

High placement quality when recommended. GoodRx holds an average recommended rank of 1.65 across all observations. Its 119 rank-one placements represent 8.3% of all observations, third highest in the category. The evidence suggests that AI systems which choose GoodRx tend to place it near the top of the shortlist rather than at the end.

Broad brand presence as a foundation. GoodRx appears in 40.3% of all observations, the second highest presence rate in the dataset. This level of visibility establishes GoodRx as a recognized category entity and provides a foundation that smaller competitors lack.

Where GoodRx Has the Clearest AI Visibility Gaps

Monthly authority value gap versus the leaders. GoodRx captures $3.07 million in monthly AI authority value, compared to Amazon Pharmacy at $8.4 million and Cost Plus Drugs at $7.33 million. Despite strong brand presence, GoodRx recommendation value is roughly one-third of either leading competitor. The gap is not explained by lower visibility alone; it reflects lower recommendation conversion at comparable presence levels.

Google AI Mode recommendation conversion failure. GoodRx appears in 42.6% of Google AI Mode observations but converts only 5.2% into valid recommendations. This is the widest visibility-to-recommendation gap across all platforms for the brand. Appearing frequently in AI Mode responses without earning recommendation credit means the brand is present as context rather than as a shortlisted option.

Comparison cluster underperformance. In the comparison and alternatives cluster, GoodRx captures only $760,000 in monthly AI authority value against Amazon Pharmacy at $2.35 million. This cluster carries a higher buyer stage multiplier of 1.25, making the gap more commercially significant than the raw dollar figures alone indicate.

Elevated neutral visibility rate. GoodRx has a neutral visibility rate of 25.3%, meaning roughly one quarter of its appearances are informational or factual references rather than recommendations. While lower than Walgreens and CVS in the same dataset, a 25.3% neutral rate represents meaningful untapped recommendation opportunity within existing visibility.

Perplexity sentiment and coverage weakness. On Perplexity, GoodRx achieves a net sentiment score of only 0.22 and a valid recommendation coverage rate of 9.5%, both below its overall averages. The brand is present on Perplexity but appears primarily as a reference rather than a recommendation.

Biggest Opportunity

The clearest path forward is converting pricing-cluster strength into comparison-cluster recommendation placement. GoodRx already earns strong AI recommendation credit when the prompt is explicitly about cost, a signal that AI systems have a clear model of what GoodRx does. The opportunity is to extend that understanding into the comparison and alternatives cluster, where buyer intent is highest and where GoodRx currently trails Amazon Pharmacy by a factor of three in monthly authority value. Strengthening the public evidence layer around side-by-side comparisons, service model differentiation, and use-case specificity for comparison prompts would directly target the cluster where the recommendation gap is widest and commercially most significant.

Prompt Evidence

Copilot / Pricing Prompt: "What is the cheapest way to get prescription medications online?" Result: GoodRx was recommended prominently, with its coupon comparison model cited as a primary cost-saving approach.

Google AI Mode / Discovery Prompt: "What are the best online pharmacies?" Result: GoodRx appeared in the response but was not placed in the recommendation shortlist, surfacing instead as a comparison anchor.

ChatGPT / Comparison Prompt: "Compare Amazon Pharmacy, Cost Plus Drugs, and GoodRx for prescription pricing." Result: GoodRx was included in the comparison but placed third, with AI systems favoring Amazon Pharmacy for convenience and Cost Plus Drugs for transparent pricing models.

Perplexity / Pricing Prompt: "How can I save money on prescriptions without insurance?" Result: GoodRx was mentioned as a relevant tool but framed as supplementary context rather than a standalone recommendation, consistent with its lower Perplexity sentiment score.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map GoodRx recommendation visibility across all prompt clusters and identify the specific prompts where competitors displace it at the comparison and evaluation stages, with particular focus on Google AI Mode and Perplexity gaps.

Phase 2: Recommendation Readiness Plan Address the Google AI Mode visibility-to-recommendation conversion gap by identifying which source types, page structures, and framing patterns are driving competitor placements on that platform.

Phase 3: Owned Answer Layer Buildout Develop structured comparison content, service model documentation, and use-case-specific pages that AI systems can retrieve and cite directly in comparison and alternatives prompts.

Phase 4: Citation / Authority Layer Development Expand the public evidence layer across editorial comparisons, third-party review sources, and authoritative references to improve recommendation framing quality in the comparison cluster specifically.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track GoodRx recommendation coverage, top-three rate, and net sentiment by platform and cluster monthly to measure progress against the Google AI Mode conversion gap and the comparison cluster value deficit.

Why This Matters

AI-generated shortlists are becoming the first filter buyers encounter when evaluating online pharmacy options. GoodRx has strong brand presence and a clear advantage in pricing prompts, but its monthly AI authority value trails the category leaders by a wide margin. In a market where the top two brands together capture a disproportionate share of total AI recommendation opportunity, being visible but under-recommended means being compared but not chosen.

The evidence points to a specific and addressable problem: GoodRx recommendation conversion is weakest exactly where buyer intent is highest, in the comparison cluster and on Google AI Mode. Closing that gap requires targeted correction of the prompt, page, and citation layers that shape how AI systems evaluate and rank GoodRx relative to Amazon Pharmacy and Cost Plus Drugs at the decision moment.

Core Metrics

• Mentions: 576
• Valid recommendations: 190
• Top 3 recommendation count: 155
• Rank 1 recommendation count: 119
• Average recommended rank: 1.65
• Positive mentions: 213
• Neutral mentions: 362
• Negative mentions: 1
• Raw mention presence rate: 40.3%
• Valid recommendation coverage: 13.3%
• Top 3 recommendation rate: 10.8%
• Rank 1 recommendation rate: 8.3%
• Monthly AI authority value (modeled benchmark): $3.07 million
• Strongest cluster by recommendation behavior: Pricing and Cost Evaluation
• Strongest platform by recommendation behavior: Copilot

Sentiment Score

Sentiment Score = (213 x 1 + 362 x 0 + 1 x -1) / 576 = 0.37

A score of 0.37 means GoodRx receives predominantly positive framing when it appears in AI responses, but a substantial share of its appearances are neutral references rather than endorsements. This distinction matters because unclassified mention counts are misleading: they treat a neutral informational reference and a positive shortlist recommendation as equivalent data points. Share of voice is a diagnostic metric, not a business outcome. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention carry materially different commercial weight. Counting all mentions as wins produces inflated visibility numbers that obscure the real recommendation conversion problem. Classified sentiment is required before any meaningful interpretation of AI visibility can be made.

Sentiment by Platform

Methodology

1. This report is an AI company market strategy report based on benchmark data from the LLM Authority Index for the online pharmacy category. It is not a client implementation case study. The findings reflect benchmark analysis of publicly observable AI recommendation behavior and should not be interpreted as client results.
2. Data collection window: June 2026, snapshot-based collection across all platforms.
3. AI platforms tested: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity.
4. Total observations analyzed: 1,431 across all platforms and clusters. Unique prompt count was not available in the public version of this dataset.
5. Competitor universe: Amazon Pharmacy, Capsule, Cost Plus Drugs, CVS Pharmacy, Express Scripts, GoodRx, Honeybee Health, Optum Rx, PillPack, and Walgreens. This universe covers the major service categories within online pharmacy but is not a full market census.
6. Public high-intent clusters analyzed: Best Online Pharmacy Discovery and Evaluation (consideration stage), Online Pharmacy Comparison and Alternatives (evaluation stage, buyer stage multiplier 1.25), and Online Pharmacy Pricing and Cost Evaluation (decision stage).
7. Definition of a mention: A mention is recorded when the company appears in an AI-generated response, regardless of framing, ranking, or sentiment. Mentions include positive recommendations, neutral references, cautionary framing, and competitor-adjacent appearances.
8. Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality appearance that earns recommendation credit in the dataset. Not all mentions qualify as valid recommendations. This distinction is the primary basis for the recommendation coverage, top-three, and rank-one metrics used throughout this report.
9. Metrics used: Raw mention presence rate, valid recommendation coverage, top-three recommendation rate, rank-one recommendation rate, average recommended rank, net sentiment score, monthly AI authority value (modeled benchmark), and captured share of AI opportunity. Modeled values are estimates based on commercial intent proxies and are not revenue figures.
10. Sentiment classification: Mentions are classified as positive, neutral, or negative. Net sentiment score is calculated as (positive x 1 + neutral x 0 + negative x -1) divided by total mentions. Framing quality reflects how AI systems characterize a brand in context, not customer satisfaction or review sentiment.
11. Limitations: This is a point-in-time benchmark. AI outputs change with model updates, retrieval source changes, and prompt variation. Modeled monthly values are benchmark estimates, not revenue, pipeline, or booked demand. This report is not a full AI audit. Platform coverage reflects the six platforms present in the dataset only.

See How AI Is Recommending Your Brand

The benchmark establishes where GoodRx stands relative to the online pharmacy category, but every brand has a different recommendation profile across platforms and prompt clusters. CiteWorks Studio can show where your brand earns recommendation credit, where competitors are being recommended instead, which prompts carry the most commercial exposure, which source types are shaping AI answers, and what needs to change to improve recommendation-stage visibility at the buyer decision moment.